Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups
Renato Bassan(Pittini Group (Italy)), Tiziano Barbui(University of Bergamo), Michele Vespignani, Teresa Lerede, G Broccia, Pierangelo Spedini(Istituti Ospitalieri di Cremona), S Morandi, Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), T Izzi, Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), Paolo Casula, Giuseppe Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Enrico Pogliani(Azienda Ospedaliera San Gerardo), Pietro Fabris(Azienda Sanitaria di Firenze), P Coser, Gianmarco Corneo, Gianmaria Borleri
Cited by 33
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k